Cited by 73Antifungal resistance and susceptibilityYeasts and Rust Fungi StudiesFungal Infections and Studies

Candida auris‒Associated Hospitalizations, United States, 2017–2022

Open access
Benedict, Kaitlin, Forsberg, Kaitlin, Gold, Jeremy A.W., Baggs, James, Lyman, Meghan·2023·Emerging Infectious Diseases

Abstract

Using a large US hospital database, we describe 192 Candida auris‒associated hospitalizations during 2017-2022, including 38 (20%) C. auris bloodstream infections. Hospitalizations involved extensive concurrent conditions and healthcare use; estimated crude mortality rate was 34%. These findings underscore the continued need for public health surveillance and C. auris containment efforts.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid2907.230540

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Candida auris, a highly transmissible and frequently multidrug-resistant Candida sp., has emerged as a cause of health care-associated outbreaks and candidemia.

    “In addition, Candida auris, a highly transmissible, and frequently multidrug-resistant Candida sp., has emerged as a cause of health care–associated outbreaks and candidemia (15,16).”

    From Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021 (2025) · cites this paper as [16]

    The opening text of our copy (section labeled Abstract; page not provided) describes C. auris as highly transmissible and frequently drug-resistant, with transmission in healthcare settings. The Abstract also reports 38 bloodstream infections and refers to outbreak investigations. It does not establish the more specific claim that C. auris is frequently multidrug-resistant; the paper says it lacked antifungal susceptibility testing data. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. [3]Park JY, Bradley N, Brooks S, Burney S, Wassner C. Management of patients with Candida auris fungemia at Community Hospital, Brooklyn, New York, USA, 2016‒2018. Emerg Infect Dis. 2019; 25: 601– 2. 10.3201/eid2503.180927 30789336 PMC6390749 · DOI
  2. [5]Simon SP, Li R, Silver M, Andrade J, Tharian B, Fu L, et al. Comparative outcomes of Candida auris bloodstream infections: a multicenter retrospective case‒control study. Clin Infect Dis. 2023; 76: e1436– 43. 10.1093/cid/ciac735 36062367 · DOI
  3. [6]Pacilli M, Kerins JL, Clegg WJ, Walblay KA, Adil H, Kemble SK, et al. Regional emergence of Candida auris in Chicago and lessons learned from intensive follow-up at 1 ventilator-capable skilled nursing facility. Clin Infect Dis. 2020; 71: e718– 25. 10.1093/cid/ciaa435 32291441 PMC8376188 · DOI · Paper page
  4. [7]Gold JAW, Seagle EE, Nadle J, Barter DM, Czaja CA, Johnston H, et al. Treatment practices for adults with candidemia at 9 active surveillance sites, United States, 2017‒2018. Clin Infect Dis. 2021; 73: 1609– 16. 10.1093/cid/ciab512 34079987 PMC8609664 · DOI · Paper page
  5. [10]Benedict K, Baggs J, Wolford H, Jackson BR, Gold JAW. Hospitalizations for unspecified mycoses in a large administrative dataset and implications for fungal disease burden estimates, United States, 2019–2021. Open Forum Infect Dis. 2023; 10: d100. 10.1093/ofid/ofad100 36968955 PMC10034590 · DOI

Cited by

Sorted by citations

Authors
Benedict, K., Forsberg, K., Gold, J. A. W., Baggs, J., & Lyman, M.
Affiliations
Centers for Disease Control and Prevention (US)
Corresponding author
Benedict, Kaitlin
Venue
Emerging Infectious Diseases
Published
2023-07
Volume
29
Issue
7
Pages
1485-1487
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W4380841315
Cited by
73
References
4
Citations by year
2026: 23 · 2025: 28 · 2024: 17 · 2023: 5
FWCI
15.11
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Emerging infectious diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Centers for Disease Control and Prevention
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
Candida auris, hospitalization, bloodstream infection, mortality, comorbidities, health care utilization, disease surveillance, United States
MeSH terms
Candida auris, Antifungal Agents, Candida, Hospitalization, Humans, United States, Candidiasis, Invasive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review